655 related articles for article (PubMed ID: 26226294)
21. Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer.
D'Souza G; Clemens G; Troy T; Castillo RG; Struijk L; Waterboer T; Bender N; Pierorazio PM; Best SR; Strickler H; Wiley DJ; Haddad RI; Posner M; Fakhry C
Cancer Prev Res (Phila); 2019 Oct; 12(10):689-700. PubMed ID: 31420362
[TBL] [Abstract][Full Text] [Related]
22. Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary.
Tanaka H; Suzuki M; Takemoto N; Fukusumi T; Eguchi H; Takai E; Kanai H; Tatsumi M; Horie M; Takenaka Y; Yachida S; Inohara H
Int J Cancer; 2022 Jan; 150(1):174-186. PubMed ID: 34486724
[TBL] [Abstract][Full Text] [Related]
23. Targeting Viral DNA and Promoter Hypermethylation in Salivary Rinses for Recurrent HPV-Positive Oropharyngeal Cancer.
Shen S; Saito Y; Ren S; Liu C; Guo T; Qualliotine J; Khan Z; Sadat S; Califano JA
Otolaryngol Head Neck Surg; 2020 Apr; 162(4):512-519. PubMed ID: 32041482
[TBL] [Abstract][Full Text] [Related]
24. Salivary High-Risk Human Papillomavirus (HPV) DNA as a Biomarker for HPV-Driven Head and Neck Cancers.
Ekanayake Weeramange C; Liu Z; Hartel G; Li Y; Vasani S; Langton-Lockton J; Kenny L; Morris L; Frazer I; Tang KD; Punyadeera C
J Mol Diagn; 2021 Oct; 23(10):1334-1342. PubMed ID: 34325059
[TBL] [Abstract][Full Text] [Related]
25. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients.
Settle K; Posner MR; Schumaker LM; Tan M; Suntharalingam M; Goloubeva O; Strome SE; Haddad RI; Patel SS; Cambell EV; Sarlis N; Lorch J; Cullen KJ
Cancer Prev Res (Phila); 2009 Sep; 2(9):776-81. PubMed ID: 19641042
[TBL] [Abstract][Full Text] [Related]
26. Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.
Kreimer AR; Johansson M; Yanik EL; Katki HA; Check DP; Lang Kuhs KA; Willhauck-Fleckenstein M; Holzinger D; Hildesheim A; Pfeiffer R; Williams C; Freedman ND; Huang WY; Purdue MP; Michel A; Pawlita M; Brennan P; Waterboer T
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376197
[TBL] [Abstract][Full Text] [Related]
27. Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.
Masterson L; Winder DM; Ball SL; Vaughan K; Lehmann M; Scholtz LU; Sterling JC; Sudhoff HH; Goon PK
BMC Cancer; 2016 Jun; 16():367. PubMed ID: 27296171
[TBL] [Abstract][Full Text] [Related]
28. Persistent Salivary Human Papillomavirus DNA as a Surveillance Biomarker: Not Just Spitting in the Wind.
Bauman JE; Ferris RL
JAMA Oncol; 2015 Oct; 1(7):915-7. PubMed ID: 26226055
[No Abstract] [Full Text] [Related]
29. Genetic variation within the human papillomavirus type 16 genome is associated with oropharyngeal cancer prognosis.
Lang Kuhs KA; Faden DL; Chen L; Smith DK; Pinheiro M; Wood CB; Davis S; Yeager M; Boland JF; Cullen M; Steinberg M; Bass S; Wang X; Liu P; Mehrad M; Tucker T; Lewis JS; Ferris RL; Mirabello L
Ann Oncol; 2022 Jun; 33(6):638-648. PubMed ID: 35306154
[TBL] [Abstract][Full Text] [Related]
30. Lead Time to Recurrence After Posttreatment Plasma and Saliva HPV DNA Testing in Patients With Low-Risk HPV Oropharynx Cancer.
Califano J; Yousef A; Mostafa H; Valsamakis A; Zhang X; Batis N; Varghese C; Parish J; Forman M; Jarrett J; Messer K; Mehanna H
JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):812-819. PubMed ID: 37498566
[TBL] [Abstract][Full Text] [Related]
31. Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma.
Chuang AY; Chuang TC; Chang S; Zhou S; Begum S; Westra WH; Ha PK; Koch WM; Califano JA
Oral Oncol; 2008 Oct; 44(10):915-9. PubMed ID: 18329326
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas.
Sedaghat AR; Zhang Z; Begum S; Palermo R; Best S; Ulmer KM; Levine M; Zinreich E; Messing BP; Gold D; Wu AA; Niparko KJ; Kowalski J; Hirata RM; Saunders JR; Westra WH; Pai SI
Laryngoscope; 2009 Aug; 119(8):1542-9. PubMed ID: 19522004
[TBL] [Abstract][Full Text] [Related]
33. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus detection in matched oral rinses, oropharyngeal and oral brushings of cancer-free high-risk individuals.
Donà MG; Pichi B; Rollo F; Benevolo M; Latini A; Laquintana V; Pellini R; Colafigli M; Frasca M; Giuliani M; Cristaudo A
Oral Oncol; 2019 Apr; 91():1-6. PubMed ID: 30926054
[TBL] [Abstract][Full Text] [Related]
35. Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners.
D'Souza G; Gross ND; Pai SI; Haddad R; Anderson KS; Rajan S; Gerber J; Gillison ML; Posner MR
J Clin Oncol; 2014 Aug; 32(23):2408-15. PubMed ID: 24778397
[TBL] [Abstract][Full Text] [Related]
36. CD8
Masterson L; Lechner M; Loewenbein S; Mohammed H; Davies-Husband C; Fenton T; Sudhoff H; Jani P; Goon P; Sterling J
Eur J Cancer; 2016 Nov; 67():141-151. PubMed ID: 27669501
[TBL] [Abstract][Full Text] [Related]
37. Population-based p16 and HPV positivity rates in oropharyngeal cancer in Southeast Scotland.
Wells LA; Junor EJ; Conn B; Pattle S; Cuschieri K
J Clin Pathol; 2015 Oct; 68(10):849-52. PubMed ID: 26152733
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus prevalence and prognostic implication in oropharyngeal squamous cell carcinomas.
Melkane AE; Auperin A; Saulnier P; Lacroix L; Vielh P; Casiraghi O; Msakni I; Drusch F; Temam S
Head Neck; 2014 Feb; 36(2):257-65. PubMed ID: 23728782
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of relapsed human papillomavirus-related oropharyngeal squamous cell carcinoma treated with curative intent.
Pipkorn P; Sinha P; Kallogjeri D; Adkins D; Thorstad WT; Rich JT; Jackson RS
Head Neck; 2019 May; 41(5):1312-1319. PubMed ID: 30536710
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status.
Huang SH; Waldron JN; Milosevic M; Shen X; Ringash J; Su J; Tong L; Perez-Ordonez B; Weinreb I; Bayley AJ; Kim J; Hope A; Cho BC; Giuliani M; Razak A; Goldstein D; Shi W; Liu FF; Xu W; O'Sullivan B
Cancer; 2015 Feb; 121(4):545-55. PubMed ID: 25336438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
